Asunto(s)
Diminazeno/análogos & derivados , Miembro Posterior/fisiopatología , Parálisis/inducido químicamente , Tripanocidas/efectos adversos , Tripanocidas/uso terapéutico , Trypanosoma brucei brucei , Tripanosomiasis/tratamiento farmacológico , Animales , Encéfalo/inmunología , Encéfalo/parasitología , Encéfalo/patología , Diminazeno/efectos adversos , Diminazeno/uso terapéutico , Femenino , Inflamación/patología , Linfocitos/inmunología , Ratones , Médula Espinal/inmunología , Médula Espinal/parasitología , Médula Espinal/patologíaRESUMEN
The 5-nitroimidazoles, MK-436 and fexinidazole dissolved in dimethylsulphoxide can be converted by the addition of hydroxypropylcellulose into gels which facilitates the ease and accuracy of administration. When these gels are used in combination with melarsoprol gel they are capable of curing experimental murine CNS-trypanosomiasis with a one-day treatment. The use of melarsoprol/MK-436 was more efficient than melarsoprol/fexinidazole gels. Thus while a single treatment with 0.1 ml 3.6% melarsoprol gel with 0.1 ml (14.3 mumol) fexinidazole gel cured the infected mice, the same dose of melarsoprol gel with 0.1 ml (4.0 mumol) of MK-436 gel was equally effective. It was also possible to prepare a combined melarsoprol/MK-436 gel which cured experimental CNS-trypanosomiasis with a single treatment. Topical treatment with this melarsoprol/MK-436 gel mixture also resolved clinically the hind leg paralysis which is associated with post-treatment reactive encephalopathy caused by non-curative treatment of CNS-trypanosomiasis.
Asunto(s)
Antiprotozoarios/administración & dosificación , Melarsoprol/administración & dosificación , Nitroimidazoles/administración & dosificación , Tripanocidas/administración & dosificación , Tripanosomiasis Africana/tratamiento farmacológico , Administración Tópica , Animales , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Femenino , Geles , RatonesRESUMEN
Both melarsomine dichlorhydrate (mel Cy, Cymelarsan) and melarsen oxide can be dissolved in dimethylsulfoxide and converted into a gel by the addition of hydroxypropylcellulose. When Trypanosoma brucei brucei-infected mice are treated topically with these gels the circulating trypanosomes are rapidly cleared from the circulation but the infections relapse soon after the last application. However, when these two compounds are allowed to react with 2,3-dimercaptopropinol (British anti-lewisite, BAL) and form "melarsoprol" their efficacy, especially in the case of mel Cy, is restored to that of commercial melarsoprol (Arsobal) and trypanosomes in the central nervous system (CNS) can be eliminated. This would indicate that the dimercaptopropinol portion of the molecule does not act solely as an "antidote" to arsenic toxicity, but also plays an important role in the absorption of melarsoprol through the skin and/or blood-brain barrier into the CNS and/or into the trypanosome.
Asunto(s)
Dimercaprol/administración & dosificación , Melarsoprol/administración & dosificación , Tripanocidas/administración & dosificación , Trypanosoma brucei brucei/efectos de los fármacos , Tripanosomiasis Africana/tratamiento farmacológico , Administración Tópica , Animales , Arsenicales/administración & dosificación , Arsenicales/farmacocinética , Arsenicales/uso terapéutico , Dimercaprol/farmacocinética , Dimercaprol/uso terapéutico , Combinación de Medicamentos , Femenino , Geles , Melarsoprol/farmacocinética , Melarsoprol/uso terapéutico , Ratones , Tripanocidas/farmacocinética , Tripanocidas/uso terapéuticoRESUMEN
Melarsoprol gel applied topically (0.1 mL for at least 2 d) can cure late-stage Trypanosoma brucei brucei and T. b. rhodesiense infections in mice. The best regimen was 3 applications at approximately 0, 6, and 24 h. The melarsoprol gel retained its activity at room temperature for at least 63 d. There was only minimal skin irritation and no sign of toxicity.